Stroke in COVID-19: A systematic review and meta-analysis
Инсульт при COVID-19: систематический обзор и метаанализ
2020-10-26
SCID: 54.1/jab98h95
Discuss with AI
COVID-19-associated strokeacute cerebrovascular diseasesacute ischemic strokelarge vessel occlusionsystematic review and meta-analysis
Figures from the paper
Abstract (AI)
BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a global pandemic, affecting millions of people. However, the relationship between COVID-19 and acute cerebrovascular diseases is unclear. AIMS: We aimed to characterize the incidence, risk factors, clinical-radiological manifestations, and outcome of COVID-19-associated stroke. METHODS: Three medical databases were systematically reviewed for published articles on acute cerebrovascular diseases in COVID-19 (December 2019-September 2020). The review protocol was previously registered (PROSPERO ID = CRD42020185476). Data were extracted from articles reporting ≥5 stroke cases in COVID-19. We complied with the PRISMA guidelines and used the Newcastle-Ottawa Scale to assess data quality. Data were pooled using a random-effect model. SUMMARY OF REVIEW: Of 2277 initially identified articles, 61 (2.7%) were entered in the meta-analysis. Out of 108,571 patients with COVID-19, acute CVD occurred in 1.4% (95%CI: 1.0-1.9). The most common manifestation was acute ischemic stroke (87.4%); intracerebral hemorrhage was less common (11.6%). Patients with COVID-19 developing acute cerebrovascular diseases, compared to those who did not, were older (pooled median difference = 4.8 years; 95%CI: 1.7-22.4), more likely to have hypertension (OR = 7.35; 95%CI: 1.94-27.87), diabetes mellitus (OR = 5.56; 95%CI: 3.34-9.24), coronary artery disease (OR = 3.12; 95%CI: 1.61-6.02), and severe infection (OR = 5.10; 95%CI: 2.72-9.54). Compared to individuals who experienced a stroke without the infection, patients with COVID-19 and stroke were younger (pooled median difference = -6.0 years; 95%CI: -12.3 to -1.4), had higher NIHSS (pooled median difference = 5; 95%CI: 3-9), higher frequency of large vessel occlusion (OR = 2.73; 95%CI: 1.63-4.57), and higher in-hospital mortality rate (OR = 5.21; 95%CI: 3.43-7.90). CONCLUSIONS: Acute cerebrovascular diseases are not uncommon in patients with COVID-19, especially in those whom are severely infected and have pre-existing vascular risk factors. The pattern of large vessel occlusion and multi-territory infarcts suggests that cerebral thrombosis and/or thromboembolism could be possible causative pathways for the disease.
Key Findings
1
Acute ischemic stroke was the predominant cerebrovascular manifestation (87.4%), whereas intracerebral hemorrhage accounted for 11.6%.
2
Among 108,571 patients with COVID-19, acute cerebrovascular disease occurred in 1.4% (95% CI: 1.0–1.9).
3
COVID-19 patients with acute cerebrovascular disease were older and more likely to have hypertension, diabetes, coronary artery disease, and severe infection.
4
COVID-19-associated acute cerebrovascular disease was particularly linked to severe COVID-19 infection.
5
Compared with non-COVID-19 stroke patients, those with COVID-19-associated stroke were younger, had higher NIHSS scores, more frequent large-vessel occlusion, and greater in-hospital mortality.
Research Object
Acute cerebrovascular diseases, particularly stroke, occurring in patients with COVID-19
Research Subject
Incidence, risk factors, clinical-radiological manifestations, and outcomes of COVID-19-associated stroke
Publication Details
Publication Date
2020-10-26
Journal
Publisher
ISSN
Cited by
610
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai8
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement2009
A pneumonia outbreak associated with a new coronavirus of probable bat origin2020
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza2020
SARS-CoV-2 and Stroke in a New York Healthcare System2020
Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-192021
Cerebral Microvascular Injury in Severe COVID-192020